New drug Nerlynx approved by the FDA as new treatment to reduce risk of breast cancer recurrence
With increasing incidences of cancer and its recurrence, the scientific community is always trying to invent new remedies and...
With increasing incidences of cancer and its recurrence, the scientific community is always trying to invent new remedies and...
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
Diabetes has become a pandemic, with hundreds of new cases being diagnosed daily. Diabetes is caused by the lack...
Stroke is one of the top 5 leading causes of death in the US alone. Moreover, it dominates the...
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...
US Food and Drug Administration (FDA) has warned both patients and doctors alike about the use of balloon angioplasty...
Skin cancer is common; however, Merkel cell carcinoma (MCC) is a rare type of aggressive skin cancer that affects...
Adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who have responded completely or partially to...